The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma

• Peiyu Yang,
• Fan Zhou,
• Yujun Dong,
• Guangxun Gao,
• Hua Xue,
• Xinyue Liang,
• Shanshan Yu,
• Weiling Xu,
• Yanping Ma,
• Xiaoqi Qin,
• Mengyao Li,
• Yun Dai,
• Fengyan Jin

Affiliations

Peiyu Yang

1 Department of Hematology, First Hospital of Jilin University, Changchun, Jilin, China

Fan Zhou

3 Department of Hematology and Oncology, Shanghai Jing’an District Zhabei Central Hospital, Shanghai, China

Yujun Dong

4 Department of Hematology, Peking University First Hospital, Beijing, China

Guangxun Gao

5 Department of Hematology, Xijing Hospital, Air Force Medical University, Xi’an, Shanxi, China

Hua Xue

6 Department of Hematology, Affiliated Hospital of Hebei University, Baoding, Hebei, China

Xinyue Liang

1 Department of Hematology, First Hospital of Jilin University, Changchun, Jilin, China

Shanshan Yu

1 Department of Hematology, First Hospital of Jilin University, Changchun, Jilin, China

Weiling Xu

7 Department of Radiology, First Hospital of Jilin University, Changchun, Jilin, China

Yanping Ma

8 Department Hematology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

Xiaoqi Qin

8 Department Hematology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

Mengyao Li

1 Department of Hematology, First Hospital of Jilin University, Changchun, Jilin, China

Yun Dai

2 Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China

Fengyan Jin

1 Department of Hematology, First Hospital of Jilin University, Changchun, Jilin, China